Results 1 to 10 of about 30,990 (280)

Disseminated Gonorrhea [PDF]

open access: yesClinical Practice and Cases in Emergency Medicine, 2020
Sexually transmitted infections have risen sharply over the last decade in the United States. The incidence of gonorrhea has risen to 172 reported cases per 100,000 people over the past year.
Janelle Estrada   +2 more
doaj   +4 more sources

Potential public health impacts of gonorrhea vaccination programmes under declining incidences: A modeling study. [PDF]

open access: yesPLoS Medicine
BackgroundGonorrhea is the second most common sexually transmitted disease notified in Singapore in 2023. Evidence suggests that the 4CMenB vaccine designed to protect against Neisseria meningitidis infection may offer partial cross-protection against ...
Lin Geng   +7 more
doaj   +2 more sources

The Impact of Educational Intervention on Willingness to Enroll in a Clinical Trial of a Gonorrhea Vaccine

open access: yesVaccines, 2023
Globally, >80 million new gonorrhea infections occur annually. Here, we assessed barriers to and influences on participation in a gonorrhea clinical trial and the impact of educational intervention. The survey was fielded in the US in March 2022.
Michael Penlington   +2 more
doaj   +1 more source

EPIDEMIOLOGICAL TRENDS OF ANTIBIOTIC-RESISTANT NEISSERIA GONORRHEA IN THE EU/EEA/EUROPEAN REGION: A SYSTEMATIC REVIEW

open access: yesHealth Problems of Civilization, 2023
Neisseria gonorrhea is becoming more resistant to available antibiotic treatments. The growing antibiotic resistance of Neisseria gonorrhea in clinical isolates has been observed by different national surveillance systems around the globe and is ...
Gurkeerat Gill
doaj   +1 more source

Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017. [PDF]

open access: yesPLoS ONE, 2018
OBJECTIVES:To estimate trends in prevalence and incidence of syphilis, gonorrhea and chlamydia in adult men and women in South Africa. METHODS:The Spectrum-STI tool estimated trends in prevalence and incidence of active syphilis, gonorrhea and chlamydia,
Ranmini S Kularatne   +7 more
doaj   +1 more source

Factors Influencing Temporary Sexual Behavior in Patients with Gonorrhea in STD Clinics [PDF]

open access: yesSHS Web of Conferences, 2022
Objective: To explore risk factors influencing temporary sexual behavior among gonorrhea patients in STD clinics, and to adapt gonorrhea prevention and control strategies accordingly.
Wang Nan
doaj   +1 more source

Treatment of Gonorrhea [PDF]

open access: bronzeJournal of Infectious Diseases, 1973
P. Frederick Sparling   +3 more
openalex   +4 more sources

Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.

open access: yesPLoS Computational Biology, 2022
In the absence of point-of-care gonorrhea diagnostics that report antibiotic susceptibility, gonorrhea treatment is empiric and determined by standardized guidelines.
Reza Yaesoubi   +6 more
doaj   +1 more source

Interruption time series analysis using autoregressive integrated moving average model: evaluating the impact of COVID-19 on the epidemic trend of gonorrhea in China

open access: yesBMC Public Health, 2023
Background Interrupted time series (ITS) analysis is a growing method for assessing intervention impacts on diseases. However, it remains unstudied how the COVID-19 outbreak impacts gonorrhea.
Yanyan Li   +5 more
doaj   +1 more source

Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016

open access: yesBMC Infectious Diseases, 2018
Background The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) performs annual sentinel surveillance of Neisseria gonorrhoeae susceptibility to therapeutically relevant antimicrobials across the European Union/European Economic Area (
Michaela J. Day   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy